CLSI Press Releases

CLSI is your source for laboratory standards news and information.

Find important updates, industry news, and information on CLSI’s upcoming events. Check out past CLSI press releases, upcoming Committees Week, and newsworthy items.

October 21, 2022

The Clinical and Laboratory Standards Institute (CLSI) has announced that a new and updated version of the I/LA37 Database, Supplemental Data for Allergen Specificity for IgE Antibody Autoanalyzers, is now available. The updated database provides essential allergen information for allergy testing manufacturers and hospitals performing allergy testing, both laboratories and clinicians. It includes a harmonized listing of the allergen codes currently used by immunoglobulin E antibody assay manufacturers, along with their common name, Latin name, and allergen grouping.

Pan American Health Organization Recognizes Clinical and Laboratory Standards Institute as an Official Non-State Actor

September 12, 2022

The Clinical and Laboratory Standards Institute (CLSI) announces that the Pan American Health Organization (PAHO) Member States have admitted CLSI into official relations as a non-state actor with PAHO for a period of three years (2022-2024). PAHO acts as the Regional Office for the Americas of the World Health Organization (WHO).

CLSI Publishes Three New Editions of Antifungal Documents

August 24, 2022

The Clinical and Laboratory Standards Institute (CLSI) has announced the publication of three new editions of antifungal documents: M57S—Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 4th Edition, M27M44S—Performance Standards for Antifungal Susceptibility Testing of Yeasts, 3rd Edition, and M38M51S—Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi, 3rd Edition.

CLSI Publishes EP14—Evaluation of Commutability of Processed Samples, 4th Edition

July 27, 2022

The Clinical and Laboratory Standards Institute has published the 4th Edition of EP14—Evaluation of Commutability of Processed Samples.

CLSI Publishes Laboratory Internal Audit Program, 2nd Edition

June 16, 2022

The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of QMS15—Laboratory Internal Audit Program. This guideline provides recommendations for establishing an internal audit program and related processes for enhanced quality and continual improvement in the laboratory.

CLSI Publishes Principles and Procedures for Blood Cultures, 2nd Edition

April 25, 2022

The Clinical and Laboratory Standards Institute (CLSI) has published the second edition of M47—Principles and Procedures for Blood Cultures.

Biotech Executive, Barbara J. Jones, Ph.D., Named New CEO of the Clinical and Laboratory Standards Institute

April 12, 2022

Biotech executive, Barbara J. Jones, Ph.D., has been named Chief Executive Officer of the Clinical and Laboratory Standards Institute (CLSI) effective May 16, 2022. The current CLSI CEO, Glen Fine, announced his retirement in January 2022 and is set to depart the organization after 17 years at the helm.

CLSI Publishes M100—Performance Standards for Antimicrobial Susceptibility Testing, 32nd Edition

March 15, 2022

The Clinical and Laboratory Standards Institute (CLSI) has published M100—Performance Standards for Antimicrobial Susceptibility Testing, 32nd Edition.

CLSI Announces New Members of Board of Directors

February 17, 2022

CLSI announces the election of three new Board members. Serving as new Directors are Collette Fitzgerald, PhD, Tania Motschman, MS, MT(ASCP)SBB, and Susan Sharp, PhD, D(ABMM), F(AAM).

CLSI publishes new guideline M39—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data

February 7, 2022

The Clinical and Laboratory Standards Institute (CLSI) has published the 5th edition of M39—Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. This guideline describes methods for recording and analyzing antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms.